ICPT

Intercept Pharmaceuticals, Inc.

1 day chart

About ICPT

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company that is focused on the development and commercialization of therapeutics to treat progressive non-viral liver diseases with unmet medical need utilizing its bile acid chemistry. Its product candidates include Ocaliva (obeticholic (OCA)) for liver fibrosis due to nonalcoholic steatohepatitis (NASH), OCA and Bezafibrate, and Other Product Candidates. The Company’s marketed product, Ocaliva, is a farnesoid X receptor (FXR) agonist for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA. The Company is evaluating tolerability of OCA in combination with bezafibrate in patients with PBC in a Phase II study outside of the United States. Its other compounds are in early stages of research and development pipeline including INT-787 compound, an FXR agonist is in a Phase IIa clinical trial.

Buy US stocks in Australia starting with ICPT. Open an account and start investing today!

Market Capitalisation

$574.63M

Price-earnings ratio

Dividend yield

0.00%

Volume

632.13K

High today

$13.97

Low today

$13.23

Open price

$13.81

52-week high

$21.86

52-week low

$10.81

ICPT FAQs

How much is one share of Intercept Pharmaceuticals, Inc.?

One share of Intercept Pharmaceuticals, Inc. is valued at $13.54.

What is the ticker symbol for Intercept Pharmaceuticals, Inc.?

The ticker symbol for Intercept Pharmaceuticals, Inc. is ICPT.

How do I buy ICPT shares in Australia?

To buy ICPT stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in ICPT

What is the 52-week high for Intercept Pharmaceuticals, Inc. stock?

The Intercept Pharmaceuticals, Inc. 52-week high stock price is $21.86.

What is the 52-week low for Intercept Pharmaceuticals, Inc. stock?

The Intercept Pharmaceuticals, Inc. 52-week low stock price is $10.81.

What is the market capitalisation of Intercept Pharmaceuticals, Inc. ICPT?

As of 31/03/2023 Intercept Pharmaceuticals, Inc. has a market cap of $575M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.